HUBBLE DRAFT Program Announcement (PA)
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in ARLINGTON, VA
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
- Advance notice of upcoming solicitation
Contract Details
- Notice ID
- DARPA-PA-26-10_DRAFT
- Opportunity Type
- Presolicitation
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)
- Office
- DEF ADVANCED RESEARCH PROJECTS AGCY
- Posted Date
- Thursday, September 24, 2026
- Response Deadline
- Friday, October 2, 2026
- PSC Code
- AC12
- Set-Aside
- No Set Aside
- Place of Performance
- ARLINGTON, VA, 222032114
- Status
- Active
Description
IMPORTANT DISCLAIMER THIS IS A PRESOLICITATION NOTICE FOR INFORMATION ONLY. The official solicitation will be issued under Notice ID: DARPA-PA-26-10. ALL INFORMATION CONTAINED HEREIN IS DRAFT AND SUBJECT TO CHANGE. In the event of any conflict, the published Program Announcement on SAM.gov takes precedence. The Defense Advanced Research Projects Agency (DARPA) anticipates soliciting proposals to develop an in-silico capability for mapping all protein-protein interactions. Utility of this capability will be demonstrated in identifying novel diagnostic and therapeutic targets within the interaction space underlying conditions including traumatic brain injury.
Why This Opportunity Matters
The Department of DEFENSE is actively seeking qualified contractors for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in ARLINGTON, VA. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
